Valeant Pharmaceuticals CFO Howard Schiller has been appointed to the drug maker's board of directors.
Canadian drug maker Valeant Pharmaceuticals International is buying Medicis Pharmaceutical for $2.6 billion, Valeant said Monday.
Valeant Pharmaceuticals is set to acquire a privately owned ophthalmic biotechnology company, the drug maker said Monday.
Mylan has completed its acquisition of two skin drugs from Valeant Pharmaceuticals, the generic drug maker said Monday.
Valeant Pharmaceuticals said it would not move forward in its pursuit of Ista Pharmaceuticals due to lack of progress.
Canadian drug maker Valeant Pharmaceuticals officially owns an Australian drug maker.
Drug maker Valeant Pharmaceuticals has launched a hostile takeover bid for ISTA Pharmaceuticals, the company said.
A former Goldman Sachs executive will join Valeant Pharmaceuticals as EVP and CFO.
Valeant Pharmaceuticals on Thursday announced the resignation of Michael Van Every from its board of directors.
Valeant Pharmaceuticals has purchased a dermatology subsidiary from Johnson & Johnson, the Canadian drug maker said Friday.
Valeant Pharmaceuticals has announced the launch of the "Change Your Skin, Change Your Life" campaign, in which its Kinerase brand will make three charitable donations in 2011.
Canadian drug maker Valeant Pharmaceuticals has proposed to buy Cephalon for $5.7 billion, Valeant said Tuesday.
J. Michael Pearson has been appointed to chairman of the board at Valeant Pharmaceuticals, the drug maker said Tuesday.
Valeant Pharmaceuticals subsidiary Biovail Labs International has licensed Canadian rights to a treatment for acne from Allergan, Valeant said Tuesday.
Valeant Pharmaceuticals' former SVP and corporate controller has been appointed to the role of interim CFO.
Teva Pharmaceuticals has launched a generic treatment for epileptic seizures....
The Food and Drug Administration has pushed back its review date for a drug made...
Valeant Pharmaceuticals has made a treatment for psoriasis available again, following a shortage, the drug...